These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 25434406)

  • 1. Gene expression profile for predicting survival of patients with meningioma.
    Chen F; Xiang CX; Zhou Y; Ao XS; Zhou DQ; Peng P; Zhang HQ; Liu HD; Huang X
    Int J Oncol; 2015 Feb; 46(2):791-7. PubMed ID: 25434406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers.
    Kandimalla R; van Tilborg AA; Kompier LC; Stumpel DJ; Stam RW; Bangma CH; Zwarthoff EC
    Eur Urol; 2012 Jun; 61(6):1245-56. PubMed ID: 22284968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma.
    Hsu PK; Kao HL; Chen HY; Yen CC; Wu YC; Hsu WH; Chou TY
    J Thorac Cardiovasc Surg; 2014 May; 147(5):1612-1618.e4. PubMed ID: 24263008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the prognosis of hepatocellular carcinoma using gene expression.
    Chang SH; Suh KS; Yi NJ; Lee KH; Kim BY; Jang JJ
    J Surg Res; 2011 Dec; 171(2):524-31. PubMed ID: 20828739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated gene expression profile predicts prognosis of breast cancer patients.
    Li LF; Xu XJ; Zhao Y; Liu ZB; Shen ZZ; Jin WR; Shao ZM
    Breast Cancer Res Treat; 2009 Jan; 113(2):231-7. PubMed ID: 18278552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiles in esophageal adenocarcinoma predict survival after resection.
    Pennathur A; Xi L; Litle VR; Gooding WE; Krasinskas A; Landreneau RJ; Godfrey TE; Luketich JD
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):505-12; discussion 512-3. PubMed ID: 23321130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data.
    Di Narzo AF; Tejpar S; Rossi S; Yan P; Popovici V; Wirapati P; Budinska E; Xie T; Estrella H; Pavlicek A; Mao M; Martin E; Scott W; Bosman FT; Roth A; Delorenzi M
    J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25246611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
    Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX
    Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
    Yu H; Levesque MA; Clark GM; Diamandis EP
    Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis.
    Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA
    Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrasting expression patterns of histone mRNA and microRNA 760 in patients with gastric cancer.
    Iwaya T; Fukagawa T; Suzuki Y; Takahashi Y; Sawada G; Ishibashi M; Kurashige J; Sudo T; Tanaka F; Shibata K; Endo F; Katagiri H; Ishida K; Kume K; Nishizuka S; Iinuma H; Wakabayashi G; Mori M; Sasako M; Mimori K
    Clin Cancer Res; 2013 Dec; 19(23):6438-49. PubMed ID: 24097871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penalized Cox regression analysis in the high-dimensional and low-sample size settings, with applications to microarray gene expression data.
    Gui J; Li H
    Bioinformatics; 2005 Jul; 21(13):3001-8. PubMed ID: 15814556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of MAGE-A9 predicts unfavorable outcome in breast cancer.
    Xu X; Tang X; Lu M; Tang Q; Zhang H; Zhu H; Xu N; Zhang D; Xiong L; Mao Y; Zhu J
    Exp Mol Pathol; 2014 Dec; 97(3):579-84. PubMed ID: 25445503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-expression of midkine and pleiotrophin predicts poor survival in human glioma.
    Ma J; Lang B; Wang X; Wang L; Dong Y; Hu H
    J Clin Neurosci; 2014 Nov; 21(11):1885-90. PubMed ID: 25001988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningiomas in children and adolescents: a meta-analysis of individual patient data.
    Kotecha RS; Pascoe EM; Rushing EJ; Rorke-Adams LB; Zwerdling T; Gao X; Li X; Greene S; Amirjamshidi A; Kim SK; Lima MA; Hung PC; Lakhdar F; Mehta N; Liu Y; Devi BI; Sudhir BJ; Lund-Johansen M; Gjerris F; Cole CH; Gottardo NG
    Lancet Oncol; 2011 Dec; 12(13):1229-39. PubMed ID: 22094004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic implications of serum microRNA-21 in colorectal cancer.
    Menéndez P; Padilla D; Villarejo P; Palomino T; Nieto P; Menéndez JM; Rodríguez-Montes JA
    J Surg Oncol; 2013 Nov; 108(6):369-73. PubMed ID: 23970420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient gender is associated with distinct patterns of chromosomal abnormalities and sex chromosome linked gene-expression profiles in meningiomas.
    Tabernero MD; Espinosa AB; Maillo A; Rebelo O; Vera JF; Sayagues JM; Merino M; Diaz P; Sousa P; Orfao A
    Oncologist; 2007 Oct; 12(10):1225-36. PubMed ID: 17962616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
    Yousef GM; Kyriakopoulou LG; Scorilas A; Fracchioli S; Ghiringhello B; Zarghooni M; Chang A; Diamandis M; Giardina G; Hartwick WJ; Richiardi G; Massobrio M; Diamandis EP; Katsaros D
    Cancer Res; 2001 Nov; 61(21):7811-8. PubMed ID: 11691797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
    Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
    Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.